Kieran Murphy was appointed President and CEO of GE Healthcare, a $17 billion business unit of General Electric in June 2017. GE Healthcare supports customers in over 100 countries with a broad range of services and systems, from diagnostic imaging and healthcare IT through to molecular diagnostics and pharmaceutical contrast agents.
Prior to this, Kieran was President and Chief Executive Officer of GE Healthcare Life Sciences, a $5.0 billion diagnostics and life sciences tools business that provided a broad range of industry-leading technologies and services for drug discovery, pre-clinical and clinical development and biopharmaceutical manufacturing, as well as molecular tools for diagnostics, therapy selection and treatment monitoring in patient care. Kieran was appointed CEO in May 2011 and oversaw significant revenue growth and geographic expansion of the molecular medicine business.
Kieran joined GE Healthcare in 2008 from Whatman plc, a London listed global supplier of filtration solutions for laboratory research, life sciences and medical diagnostic applications. Kieran has over thirty years’ experience in the global life sciences and biotechnology industry, beginning his career with Janssen Pharmaceutical, a division of Johnson and Johnson, followed by leadership roles with Mallinckrodt, Novartis, Adprotech, and Innovata plc.
He is a graduate of University College, Dublin and Manchester University business school.